Oncocross Begins Clinical Trial for AI-Developed Drug for Sarcopenia

SEOUL, South Korea--(BUSINESS WIRE)--#AIBiotech--Oncocross, an AI-based drug development biotech, announced that it initiated a phase…

India Industrial Automation Market (2022 to 2027) – Growth, Trends, COVID-19 Impact, and Forecasts – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--India Industrial Automation Market (2022 to 2027) - Growth, Trends, COVID-19 Impact, and Forecasts…

Hungry Sausages Lab’s First NFT Collection Connects Digital Content to the Physical World as Uses Expand

HONG KONG SAR - Media OutReach - 25 February 2022 - Hungry Sausage Lab, a…

U.S. & Japan $796.5 Million Collagen Supplements Market to 2030: Increase in the Popularity of Gummies Likely to Foster Market Growth – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "U.S. & Japan Collagen Supplements Market by Source, Form and Sales Channel: Country…

BeiGene Reports Fourth Quarter and Full Year 2021 Financial Results

Recorded product revenue of $196.8 million and $634.0 million for the fourth quarter and full…

Spackman Media Group Artist Son Ye-Jin’s New K-Drama, 39, Breaks Its Own Highest Record In Audience Rating Since Its Premiere In Korea

Represented by MSteam, a wholly-owned subsidiary of Spackman Media Group, Son Ye-jin stars in JTBC’s…

KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Approved in Japan for Radically Unresectable or Metastatic Renal Cell Carcinoma

Results From CLEAR/KEYNOTE-581 Showed KEYTRUDA Plus LENVIMA Significantly Reduced the Risk of Disease Progression or…

KE Holdings Inc. to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 9, 2022 Eastern Time

BEIJING--(BUSINESS WIRE)--KE Holdings Inc. (“Beike” or the “Company”) (NYSE: BEKE), a leading integrated online and…

Strategic Education, Inc. Reports Fourth Quarter 2021 Results

HERNDON, Va.--(BUSINESS WIRE)--Strategic Education, Inc. (Strategic Education) (NASDAQ: STRA) today announced financial results for the…